Medication adherence is a long-standing problem, but the dawning of the patient-centric age is opening up new ways to save lives and maximise returns. That’s according to John Ragland, chief product ...
In Part 1 of this article, we addressed the more than $100 billion US nonadherence epidemic and the health tech companies developing solutions to solve it. In evaluating several early stage companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback